The Role of Specialty Pharmacists in Overcoming Barriers Associated With PCSK9 Inhibitors
Pharmacy Times,
Introduction Atherosclerotic cardiovascular disease (ASCVD) is a common condition that is treated with lipid-lowering agents.
Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association
Overview of attention for article published in Journal of Clinical Lipidology, May 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (91st percentile)
-
High Attention Score compared to outputs of the same age and source (88th percentile)
Readers on
- mendeley
- 66 Mendeley
